Subscription pull incentives—when countries pay yearly amounts to manufacturers for access to needed antibiotics—could help Canada have access to more new antibiotics and grow the pipeline as well.
The current legal mechanisms surrounding MAiD are extremely complex for dementia sufferers and their loved ones. How might parameters improve in the future?